pISSN 2636-0004
eISSN 2636-0012

Table. 1.

Patients’ Baseline Characteristics

IBS group
(n = 30)
Non-IBS group
(n = 38)
P-value
Age (yr) 64.2 ± 6.3 66.7 ± 5.5 0.10
Sex (M/F) 18/12 30/8 0.11
Cirrhosis etiology
HBV 2 (6.7) 3 (7.8)
HCV 16 (53.3) 23 (60.5)
Alcohol 4 (13.3) 5 (13.2)
NASH/NAFLD 3 (10.0) 2 (5.3)
Others 5 (16.7) 5 (13.2)
Natural MELD at transplant (point) 8 (5–30) 10 (5–21) 0.48
Locoregional bridge therapy 23 (76.7) 33 (86.8) 0.344
TACE 14 23
RFA 3 3
Y90 0 1
Combination 9 4
Nil 4 7
TTV (cm3) 15.3 ± 17.6 11.5 ± 15.1 0.14
AFP (μg/L) 10.8 (1.0–342.0) 14.6 (2.0–3,395.0) 0.53
HCC recurrence 5 (16.7) 1 (2.6) 0.03*
Int J Gastrointest Interv 2023;12:145~151 https://doi.org/10.18528/ijgii230020
© Int J Gastrointest Interv